Dr Reddy's Laboratories on Friday said it has launched a generic medication, used to treat a wide variety of bacterial infections, in the US market.
The company has launched Doxycycline Capsules (40 mg) in the US market, the Hyderabad-based drug maker said in a statement.
The company's product is a therapeutic generic equivalent of Oracea capsules (40 mg) approved by the US Food and Drug Administration.
Shares of the company on Friday ended 0.71% up at Rs 6,332.85 apiece on the BSE.
ADVERTISEMENT
RECOMMENDED FOR YOU
I'm Not Enjoying Playing Chess: Carlsen After Defeat To Gukesh
Jul 04, 2025
.jpeg?rect=0%2C0%2C3500%2C1969&w=75)
'Buy' JSW Infra Shares Maintains Motilal Oswal On Strong Balance Sheet, Favorable Macro
Jul 04, 2025
India Initiates Anti-Dumping Probe Into Multi-Layer Paperboard Import From Indonesia
Jul 03, 2025
Oil Declines With Trade Deal Progress, OPEC+ Decision In Focus
Jul 03, 2025
POPULAR
1
Safex Chemicals Files Draft Papers For Rs 450 Cr IPO
2
India-US Trade Deal: Where Talks Stand, What's Holding Them Back — Here's What We Know So Far
3
Sushil Kedia Issues Clarification On Marathi Language Row As MNS Workers Vandalise Office
4
Raj From DDLJ Is No Indian Woman's Dream In 2025 — Here's What They Want In Their Partner
5